This blog is a news aggregation of life extension related articles coming from reputable sources.

Looking for our regular content? click here

One of the more interesting aspects of the various epigenetic clocks that have been developed in recent years is that it is still largely unknown as to what exactly it is that they are assessing in our aging biochemistry. These clocks are weighted measures of epigenetic markers, such as DNA methylation, over a comparatively small…

Many other species are more regenerative than we are, and mammals in general are less regenerative than is the case for some other clades. It is too early to say whether ongoing investigations of the basis for proficient regeneration will lead to ways to safely adjust our biochemistry to perform greater feats of healing. Even…

Adult, or somatic, stem cells support surrounding tissues by delivering a supply of daughter somatic cells, ready to replace those lost over time. This stem cell activity declines with age, and in the best studied stem cell populations this appears to be more a matter of signaling than a matter of inherent dysfunction. Stem cells…

IMAGE: This is Pradeep Bhide, the Jim and Betty Ann Rodgers Eminent Scholar Chair of Developmental Neuroscience at the College of Medicine. view more  Credit: FSU College of Medicine TALLAHASSEE, Fla. — While women have long been warned about the dangers of smoking during pregnancy, far less has been known about risks for offspring of men…

Colorectal cancer patients who followed healthy diets had a lower risk of death from colorectal cancer and all causes, even those who improved their diets after being diagnosed, according to a new American Cancer Society study. There are more than 1.4 million colorectal cancer (CRC) survivors in the United States. Previous studies have suggested a…

Munich, Germany, 20 October 2018 – Including exercise or sport as part of cancer care can significantly improve symptom management, quality of life and fitness during and after treatment, French researchers have concluded in two presentations to be reported at the ESMO 2018 Congress in Munich. Even among patients at highest risk of poor quality…

IMAGE: Dr. Quan Tran, Medical Oncologist at the Cancer Care Centre, St Stephen’s Hospital, Urraween, Australia, study author view more  view more  Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 – Most people with lung cancer are unaware of the benefits of regular exercise, yet new data show it can significantly reduce…

Munich, Germany, 20 October 2018 – Social vulnerability showed to be a major limitation to participation in cancer screening for four tumors types – breast, cervical, colorectal and lung – according to the French nationwide observational survey, EDIFICE 6. Also, a disbelief in cancer test efficacy among target populations was highlighted as new indicator of…

IMAGE: Dr. Aurélien Gobert of Groupe Hospitalier Pitié Salpêtrière in Paris, France, study author. view more  view more  Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 – Immunotherapy has been a major breakthrough in oncology, with registered drugs now approved for use in an increasing number of tumour types – but little…

IMAGE: Migration of primordial germ cells in the human embryo. view more  Credit: © Laurence Zulianello Among several forms of pancreatic cancer, one of them affects specifically women, often young. How is this possible, even though the pancreas is an organ with little exposure to sex hormones? This pancreatic cancer, known as “mucinous cyst”, has strange…

IMAGE: Dr. Jérôme Martin-Babau from Centre Armoricain de Radiothérapie, Imagerie Médicale et Oncologie in Plérin, France, study author. view more  view more  Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 – Chemotherapy is known to have a negative impact on the reproductive potential of young breast cancer patients. Its effects on women’s…

Munich, Germany, 19 October 2018 – Some European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs following their approval by the European Medicines Agency (EMA). The average decision time is longer than one year in some countries, according to a study to…

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD